It can also act at insulin‐sensitive tissues such as muscle, liver, and adipose tissue resulting in an insulin‐resistant state, leading to promotion of diabetes and metabolic disorders such as the metabolic syndrome. This evidence concerns the gene INS and metabolic syndrome.